What is the appropriate treatment for genital molluscum contagiosum?

Treatment for Genital Molluscum Contagiosum

For symptomatic genital molluscum contagiosum, physical destruction of lesions through cryotherapy, curettage, or excision is the most effective approach, as these methods provide immediate removal and prevent viral shedding onto the genital mucosa. 1, 2, 1

Primary Treatment Approach

The key distinction with genital molluscum is that treatment is indicated for symptomatic patients rather than waiting for spontaneous resolution, because viral shedding from eyelid or genital lesions causes ongoing conjunctivitis/keratitis or transmission risk 1, 2, 1. While the provided guidelines primarily address periocular molluscum, the treatment principles apply directly to genital lesions.

First-Line Physical Treatments

Provider-administered physical destruction:

• Incision and curettage (must be aggressive enough to cause bleeding to ensure complete removal) 1, 2, 1
• Simple excision with or without cautery 1, 2, 1
• Cryotherapy with liquid nitrogen 1, 2, 1, 3

These methods achieve clearance rates of 73.8-97.8% with minimal side effects 4. The bleeding induced by aggressive curettage is intentional—it reduces viral load sufficiently to allow the host immune response to eliminate residual virus 1, 2, 1.

Critical Management Points

Identify and treat ALL lesions, including nascent ones, to reduce recurrence risk 1, 2, 1. This is particularly important in genital molluscum where multiple small lesions may be present.

Expect delayed resolution of associated symptoms: If there is concurrent genital inflammation or discomfort, symptoms may require weeks to resolve even after complete lesion removal 1, 2, 1.

Alternative and Adjunctive Treatments

Topical Chemical Agents

Based on recent research evidence, several topical options show efficacy:

Potassium hydroxide (KOH):

• 20% KOH solution applied once or twice daily 5
• Clearance achieved in 20-31 days for genital lesions 5
• Side effects: stinging/burning, erosions, post-inflammatory pigment changes (tolerable) 5
• 10% KOH also effective with high clearance rates (73.8%) 4

Podophyllotoxin:

• 75% clearance rate 4
• Well-established for genital warts; applicable to genital molluscum 3

Imiquimod 5% cream:

• 75% clearance rate in genital molluscum 6
• Applied daily; most common side effect is erythema (24% of patients) 6
• Activates immune response through cytokine induction 6

Emerging Therapies

Autoinoculation technique:

• 79.4% clearance rate 4
• Simple procedure: pierce one lesion with 30G needle to induce cell-mediated immune response 7
• 60% of patients show excellent response with clearance of both local and distant lesions 7
• Particularly useful when multiple lesions present 7

Special Populations

Immunocompromised Patients

Large, multiple molluscum lesions with minimal inflammation suggest immunocompromised state 1, 2, 1. These patients require:

• More aggressive treatment approaches 3
• Consider cidofovir, imiquimod, or interferon for severe/recalcitrant cases 3
• Referral to specialist for management 1, 2, 1

Pregnancy

Physical procedures (cryotherapy, excision) are safe in pregnancy 3. Avoid podophyllotoxin and other topical agents with uncertain safety profiles.

Treatment Algorithm

1. Confirm diagnosis clinically (dome-shaped, umbilicated papules 2-5mm)
2. Identify all lesions including nascent ones
3. First choice: Cryotherapy or curettage (with bleeding) for immediate removal
4. If physical treatment declined or impractical: 20% KOH twice daily or podophyllotoxin
5. If multiple lesions: Consider autoinoculation technique
6. If immunocompromised: Refer to specialist; consider imiquimod or systemic therapy
7. Screen for other STIs in all patients with genital molluscum 3

Common Pitfalls

• Incomplete treatment of nascent lesions leads to recurrence 1, 2, 1
• Insufficient curettage (not causing bleeding) may leave viral particles 1, 2, 1
• Expecting immediate symptom resolution—inflammation may persist for weeks after lesion removal 1, 2, 1
• Missing immunocompromised state in patients with extensive, minimally inflamed lesions 1, 2, 1

Note: The evidence provided focuses heavily on genital warts (HPV) rather than molluscum contagiosum. The most relevant guidelines for genital molluscum treatment come from ophthalmology literature addressing periocular lesions 1, 2, 1 and recent European guidelines 3, with treatment principles being directly applicable to genital sites.